Yamaji Yutaka, Okamoto Makoto, Yoshida Haruhiko, Kawabe Takao, Wada Ryoichi, Mitsushima Toru, Omata Masao
Department of Gastroenterology, University of Tokyo, Tokyo, Japan.
Am J Gastroenterol. 2008 Aug;103(8):2061-7. doi: 10.1111/j.1572-0241.2008.01936.x.
Obesity is thought to be associated with colorectal cancer and adenoma. We aimed to investigate the effect of body weight on the risk of colorectal adenoma both in cross-sectional and longitudinal analyses.
This is a retrospective cohort study in a large-scale health appraisal institution in Japan. A total of 7,963 asymptomatic, average-risk Japanese were enrolled at initial examinations, and 2,568 subjects who underwent a second colonoscopy after 1 yr were investigated. The association with the prevalence of colorectal adenoma was evaluated according to the body mass index (BMI) at the initial examination. The incidence of colorectal adenoma at the second colonoscopy was investigated according to the initial BMI and body weight changes during the year.
The prevalence of colorectal adenoma increased in relation to increases in the BMI: 15.4%, 20.6%, 22.7%, and 24.2%, respectively, in the first (BMI < 21.350), second (21.350 < or = BMI < 23.199), third (23.199 < or = BMI < 25.156), and fourth (25.156 < or = BMI) quartiles. The adjusted odds ratios in reference to Group Q1 were 1.15 (95% CI 0.97-1.37, P= 0.1) for Group Q2, 1.19 (1.01-1.41, P= 0.04) for Group Q3, and 1.32 (1.12-1.56, P= 0.001) for Group Q4. The incidence rates of colorectal adenoma after 1 yr also increased proportionally according to the initial BMI: Group Q1 (12.9%), Group Q2 (15.7%), Group Q3 (18.3%), and Group Q4 (19.0%).
Obesity was associated with the risk for colorectal adenoma, and body weight reduction was suggested to decrease this risk.
肥胖被认为与结直肠癌及腺瘤有关。我们旨在通过横断面分析和纵向分析,研究体重对结直肠腺瘤风险的影响。
这是一项在日本一家大型健康评估机构进行的回顾性队列研究。共有7963名无症状、平均风险的日本人在初次检查时入组,对其中2568名在1年后接受第二次结肠镜检查的受试者进行了调查。根据初次检查时的体重指数(BMI)评估与结直肠腺瘤患病率的关联。根据初次BMI及一年内体重变化情况,调查第二次结肠镜检查时结直肠腺瘤的发病率。
结直肠腺瘤的患病率随BMI升高而增加:在第一(BMI<21.350)、第二(21.350≤BMI<23.199)、第三(23.199≤BMI<25.156)和第四(25.156≤BMI)四分位数组中,患病率分别为15.4%、20.6%、22.7%和24.2%。与第一四分位数组相比,第二四分位数组的校正比值比为1.15(95%可信区间0.97 - 1.37,P = 0.1),第三四分位数组为1.19(1.01 - 1.41,P = 0.04),第四四分位数组为1.32(1.12 - 1.56,P = 0.001)。1年后结直肠腺瘤的发病率也根据初次BMI成比例增加:第一四分位数组(12.9%)、第二四分位数组(15.7%)、第三四分位数组(18.3%)和第四四分位数组(19.0%)。
肥胖与结直肠腺瘤风险相关,建议减轻体重以降低此风险。